The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Arch Venture Fund Viii Overage, L.p. since 2023.
This trader's CIK number is 1617237.
At the time of last reporting, Arch Venture Fund Viii Overage, L.p. was the 10% Owner of Neumora Therapeutics, Inc.. (stock ticker symbol NMRA).
Also see all insider trading activities at Neumora Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NMRA | 1,500,000 | $25,500,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-19 | NMRA | Buy | 1,500,000 | 17.00 | 25,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arch Venture Fund Viii Overage, L.p. (10% Owner of Neumora Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.